Abbott FreeStyle Libre 2 Plus

FreeStyle Libre 2 Plus is a continuous glucose monitoring (CGM) system designed for real-time tracking of glucose levels. The product is manufactured by Abbott Diabetes Care, a division of the global healthcare leader Abbott Laboratories. While Abbott is headquartered in the United States, its manufacturing operations for the FreeStyle Libre portfolio are global. Notably, the company recently opened a major state-of-the-art facility in Kilkenny, Ireland, which is designated to have the highest production of Libre sensors in the world to meet surging global demand. Additionally, production and assembly take place in other regions to support its distribution in over 60 countries.

The brand's history is rooted in Abbott's long-standing expertise in medical diagnostics. The FreeStyle brand itself gained significant momentum following Abbott's 2004 acquisition of TheraSense, which was subsequently merged with its MediSense division to form Abbott Diabetes Care. Today, Abbott remains the ultimate owner of the brand, continuing to innovate the technology for better diabetes management worldwide.